{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:22:56Z","timestamp":1792423376028,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:p>\n                    We sought to identify novel pharmacogenetic markers associated with cardiovascular outcomes in patients with hypertension on antihypertensive therapy. We genotyped a 1:4 case:control cohort (n=1345) on the Illumina HumanCVD Beadchip from the INternational VErapamil SR\u2013Trandolapril STudy (INVEST), where participants were randomized to a \u03b2-blocker strategy or a calcium channel blocker strategy. Genome-spanning single nucleotide polymorphism (SNP)\u00d7treatment interaction analyses of nonsynonymous SNPs were conducted in white and Hispanic race\/ethnic groups. Top hits from whites were tested in Hispanics for consistency. A genetic risk score was constructed from the top 3 signals and tested in the Nordic Diltiazem study.\n                    <jats:italic>SIGLEC12<\/jats:italic>\n                    rs16982743 and\n                    <jats:italic>A1BG<\/jats:italic>\n                    rs893184 had a significant interaction with treatment strategy for adverse cardiovascular outcomes (INVEST whites and Hispanics combined interaction\n                    <jats:italic>P<\/jats:italic>\n                    =0.0038 and 0.0036, respectively). A genetic risk score, including rs16982743, rs893184, and rs4525 in\n                    <jats:italic>F5<\/jats:italic>\n                    , was significantly associated with treatment-related adverse cardiovascular outcomes in whites and Hispanics from the INVEST study and in the Nordic Diltiazem study (meta-analysis interaction\n                    <jats:italic>P<\/jats:italic>\n                    =2.39\u00d710\n                    <jats:sup>\u22125<\/jats:sup>\n                    ). In patients with a genetic risk score of 0 or 1, calcium channel blocker treatment was associated with lower risk (odds ratio [95% confidence interval]=0.60 [0.42\u20130.86]), and in those with a genetic risk score of 2 to 3, calcium channel blocker treatment was associated with higher risk (odds ratio [95% confidence interval]=1.31 [1.08\u20131.59]). These results suggest that cardiovascular outcomes may differ based on\n                    <jats:italic>SIGLEC12, A1BG<\/jats:italic>\n                    ,\n                    <jats:italic>F5<\/jats:italic>\n                    genotypes, and antihypertensive treatment strategy. These specific genetic associations and our risk score provide insight into a potential approach to personalized antihypertensive treatment selection.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.111.00823","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T01:07:57Z","timestamp":1369098477000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Pharmacogenomic Association of Nonsynonymous SNPs in\n                    <i>SIGLEC12<\/i>\n                    ,\n                    <i>A1BG<\/i>\n                    , and the Selectin Region and Cardiovascular Outcomes"],"prefix":"10.1161","volume":"62","author":[{"given":"Caitrin W.","family":"McDonough","sequence":"first","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gong","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Burkley","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taimour Y.","family":"Langaee","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Melander","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Pepine","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna F.","family":"Dominiczak","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda M.","family":"Cooper-DeHoff","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy (C.W.M., Y.G., B.B., T.Y.L., R.M.C.-D., J.A.J.), and Division of Cardiovascular Medicine, Department of Medicine (C.J.P., R.M.C.-D., J.A.J.), University of Florida, Gainesville, FL; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (S.P., A.F.D.); and Department of Clinical Sciences,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31823ac046"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304013281303"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003583"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.21.2805"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02526-5"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/519795"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bth457"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq340"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804742"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61267-6"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.244152"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102394200"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.66.5.705"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi048823e"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0290"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3259.bloodjournal8893259"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2009.94"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030120"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32832933b7"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/hq1001.097022"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.17.2015"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004390000325"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/510918"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/3.11.1935"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000140740.19421.fe"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283516ff8"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.111.00823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:01:51Z","timestamp":1715576511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.111.00823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.111.00823"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.111.00823","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718015769.793477706","asserted-by":"object"}]},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"2012-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-05-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}